CDK7-IN-13

CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1) [1].

Product Specifications

CAS Number

[2765676-20-6]

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cdk7-in-13.html

Solubility

10 mM in DMSO

Smiles

CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F

Molecular Formula

C20H23F3N6OS

Molecular Weight

452.50

References & Citations

[1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-24062PCP 0.1 mL

Rabbit Monoclonal CD40/TNFRSF5 Antibody (C40/9225R) [PerCP]

Ask

View Details

CP7222-1mg 1 mg

Peptide 271

Ask

View Details

MBS1453659-01 0.02 mg (E-Coli)

Recombinant Bacillus anthracis Ribonuclease HIII (rnhC)

Ask

View Details

MBS1453659-02 0.02 mg (Yeast)

Recombinant Bacillus anthracis Ribonuclease HIII (rnhC)

Ask

View Details

MBS1453659-03 0.1 mg (E-Coli)

Recombinant Bacillus anthracis Ribonuclease HIII (rnhC)

Ask

View Details

MBS1453659-04 0.1 mg (Yeast)

Recombinant Bacillus anthracis Ribonuclease HIII (rnhC)

Ask

View Details